Why the study?
Does systolic impairment increase the risk of death or cardiac transplantation in patients with hypertrophic cardiomyopathy?
Does systolic impairment increase the risk of death or cardiac transplantation in patients with hypertrophic cardiomyopathy?
Systolic impairment is an infrequent complication of hypertrophic cardiomyopathy but is associated with a significantly increased risk of death or cardiac transplantation.
Authors
No takes yet. Share an insight, caveat, or question.
May warrant closer surveillance in HCM with systolic impairment; extends prior cohorts but leaves open therapeutic implications.
Rajesh Thaman (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: